Hers, Hims and Super Bowl
Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and obesity, respectively.
During Sunday’s Super Bowl, Hims & Hers Health ... to life-saving weight loss treatments.” The ad is just the latest flashpoint in a battle over compounded GLP-1 drugs.
But while Hims’ ad touts its ability to prescribe and dispense GLP-1 drugs to patients, with text and claims about weight-loss drugs and imagery of a pale-blue injection pen (resembling an ...
A Super Bowl ad touting Hims & Hers Health Inc.’s copycat weight-loss drugs is getting pushback ... and efficacy of their knockoff GLP-1 medicines,” the drug industry’s main lobbying group ...
Ahead of the Super Bowl, telehealth company Hims & Hers on Jan. 28 released a provocative commercial attacking the weight loss industry ... of blockbuster GLP-1 drugs like Wegovy are ...
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers ... for Safe Medicines said the 1-minute ad is "misleading in ...
In the 60-second spot set to Childish Gambino’s "This is America," Hims & Hers criticized large pharmaceutical companies and claimed popular glucagon-like peptide-1 agonist weight loss drugs ...
Telehealth company Hims & Hers has ... to doctor-trusted weight-loss treatment plans tailored to your needs for long-term success.” Taking a compounded GLP-1 medication isn’t the same thing ...
That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss ... of these medications, known as compounded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback